Literature DB >> 16997715

Virus-like particles production in green plants.

Luca Santi1, Zhong Huang, Hugh Mason.   

Abstract

Viruses-like particles (VLPs), assembled from capsid structural subunits of several different viruses, have found a number of biomedical applications such as vaccines and novel delivery systems for nucleic acids and small molecules. Production of recombinant proteins in different plant systems has been intensely investigated and improved upon in the last two decades. Plant-derived antibodies, vaccines, and microbicides have received great attention and shown immense promise. In the case of mucosal vaccines, orally delivered plant-produced VLPs require minimal processing of the plant tissue, thus offering an inexpensive and safe alternative to more conventional live attenuated and killed virus vaccines. For other applications which require higher level of purification, recent progress in expression levels using plant viral vectors have shown that plants can compete with traditional fermentation systems. In this review, the different methods used in the production of VLPs in green plants are described. Specific examples of expression, assembly, and immunogenicity of several plant-derived VLPs are presented.

Mesh:

Substances:

Year:  2006        PMID: 16997715      PMCID: PMC2677071          DOI: 10.1016/j.ymeth.2006.05.020

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  107 in total

1.  HPV6b virus like particles are potent immunogens without adjuvant in man.

Authors:  L F Zhang; J Zhou; S Chen; L L Cai; Q Y Bao; F Y Zheng; J Q Lu; J Padmanabha; K Hengst; K Malcolm; I H Frazer
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

Review 2.  Direct DNA transfer to plant cells.

Authors:  M R Davey; E L Rech; B J Mulligan
Journal:  Plant Mol Biol       Date:  1989-09       Impact factor: 4.076

3.  Application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis.

Authors:  S Tsuda; K Yoshioka; T Tanaka; A Iwata; A Yoshikawa; Y Watanabe; Y Okada
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

4.  Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

Authors:  D R Milich; G B Thornton; A R Neurath; S B Kent; M L Michel; P Tiollais; F V Chisari
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

5.  Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen.

Authors:  Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

6.  Nanoparticles for the delivery of genes and drugs to human hepatocytes.

Authors:  Tadanori Yamada; Yasushi Iwasaki; Hiroko Tada; Hidehiko Iwabuki; Marinee K L Chuah; Thierry VandenDriessche; Hideki Fukuda; Akihiko Kondo; Masakazu Ueda; Masaharu Seno; Katsuyuki Tanizawa; Shun'ichi Kuroda
Journal:  Nat Biotechnol       Date:  2003-06-29       Impact factor: 54.908

7.  Viral hepatitis, type B. Studies on natural history and prevention re-examined.

Authors:  S Krugman; L R Overby; I K Mushahwar; C M Ling; G G Frösner; F Deinhardt
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

8.  Involvement of the terminus of grouper betanodavirus capsid protein in virus-like particle assembly.

Authors:  M W Lu; C S Lin
Journal:  Arch Virol       Date:  2003-02       Impact factor: 2.574

9.  Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells.

Authors:  E J Patzer; G R Nakamura; A Yaffe
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum.

Authors:  Y H Joung; J W Youm; J H Jeon; B C Lee; C J Ryu; H J Hong; H C Kim; H Joung; H S Kim
Journal:  Plant Cell Rep       Date:  2004-03-27       Impact factor: 4.570

View more
  30 in total

1.  Impaired plant growth and development caused by human immunodeficiency virus type 1 Tat.

Authors:  Marni E Cueno; Yurina Hibi; Kenichi Imai; Antonio C Laurena; Takashi Okamoto
Journal:  Transgenic Res       Date:  2010-01-20       Impact factor: 2.788

2.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

Review 3.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

4.  A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.

Authors:  Simone Grasso; Chiara Lico; Francesca Imperatori; Luca Santi
Journal:  Transgenic Res       Date:  2012-10-30       Impact factor: 2.788

Review 5.  Using viruses as nanomedicines.

Authors:  H E van Kan-Davelaar; J C M van Hest; J J L M Cornelissen; M S T Koay
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 6.  Vaccine against norovirus.

Authors:  Ming Tan; Xi Jiang
Journal:  Hum Vaccin Immunother       Date:  2014-05-05       Impact factor: 3.452

7.  Spurious polyadenylation of Norovirus Narita 104 capsid protein mRNA in transgenic plants.

Authors:  Lolita G Mathew; Bryan Maloney; Naokazu Takeda; Hugh S Mason
Journal:  Plant Mol Biol       Date:  2011-01-04       Impact factor: 4.076

Review 8.  Norwalk virus-like particles as vaccines.

Authors:  Melissa Herbst-Kralovetz; Hugh S Mason; Qiang Chen
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

9.  Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.

Authors:  Michael J Springer; Yawei Ni; Isaac Finger-Baker; Jordan P Ball; Jessica Hahn; Ashley V DiMarco; Dean Kobs; Bobbi Horne; James D Talton; Ronald R Cobb
Journal:  Vaccine       Date:  2016-02-10       Impact factor: 3.641

10.  Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.

Authors:  Anderson Paul Kanagaraj; Dheeraj Verma; Henry Daniell
Journal:  Plant Mol Biol       Date:  2011-03-24       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.